These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 375883)

  • 41. Effect of ACEA--a selective cannabinoid CB1 receptor agonist on the protective action of different antiepileptic drugs in the mouse pentylenetetrazole-induced seizure model.
    Andres-Mach M; Zolkowska D; Barcicka-Klosowska B; Haratym-Maj A; Florek-Luszczki M; Luszczki JJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):301-9. PubMed ID: 22789660
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Valproate sodium: a controlled clinical trial including monitoring of drug levels.
    Gram L; Wulff K; Rasmussen KE; Flachs H; Würtz-Jorgensen A; Sommerbeck KW; Lohren V
    Epilepsia; 1977 Jun; 18(2):141-8. PubMed ID: 326542
    [No Abstract]   [Full Text] [Related]  

  • 43. The effect of concurrent administration of sodium valproate on serum levels of primidone and its metabolite phenobarbital.
    Yukawa E; Higuchi S; Aoyama T
    J Clin Pharm Ther; 1989 Oct; 14(5):387-92. PubMed ID: 2511216
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of therapeutic drug level monitoring of phenobarbital, phenytoin and carbamazepine in Iranian epileptic patients.
    Babaei A; Eslamai MH
    Int J Clin Pharmacol Ther; 2007 Feb; 45(2):121-5. PubMed ID: 17323792
    [TBL] [Abstract][Full Text] [Related]  

  • 45. N-(anilinomethyl)-p-isopropoxyphenylsuccinimide potentiates the anticonvulsant action of phenobarbital and valproate in the mouse maximal electroshock-induced seizure model.
    Luszczki JJ; Kocharov SL; Czuczwar SJ
    Neurosci Res; 2009 Jul; 64(3):267-72. PubMed ID: 19447295
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Psychiatric aspects of epilepsy in childhood treated with carbamazepine, phenytoin or sodium valproate: a random trial.
    Berg I; Butler A; Ellis M; Foster J
    Dev Med Child Neurol; 1993 Feb; 35(2):149-57. PubMed ID: 8444328
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Is valproate monotherapy a practical possibility in chronically uncontrolled epilepsy?
    Armour DJ; Veitch GB
    J Clin Pharm Ther; 1988 Feb; 13(1):53-64. PubMed ID: 3129441
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A comparison of phenytoin and valproate in previously untreated adult epileptic patients.
    Turnbull DM; Rawlins MD; Weightman D; Chadwick DW
    J Neurol Neurosurg Psychiatry; 1982 Jan; 45(1):55-9. PubMed ID: 6801213
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy and safety of intravenous sodium valproate versus phenobarbital in controlling convulsive status epilepticus and acute prolonged convulsive seizures in children: a randomised trial.
    Malamiri RA; Ghaempanah M; Khosroshahi N; Nikkhah A; Bavarian B; Ashrafi MR
    Eur J Paediatr Neurol; 2012 Sep; 16(5):536-41. PubMed ID: 22326977
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Therapeutic and pharmacokinetic effects of increasing phenytoin in chronic epileptics on multiple drug therapy.
    Lambie DG; Johnson RH; Nanda RN; Shakir RA
    Lancet; 1976 Aug; 2(7982):386-9. PubMed ID: 73851
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Anticonvulsant action of di-N-propylacetate combined with benzodiazepines, phenobarbital and phenytoin].
    Kosoĭ MIu
    Biull Eksp Biol Med; 1981 Apr; 91(4):458-60. PubMed ID: 6114759
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reduction of serum carnitine concentrations during anticonvulsant therapy with phenobarbital, valproic acid, phenytoin, and carbamazepine in children.
    Hug G; McGraw CA; Bates SR; Landrigan EA
    J Pediatr; 1991 Nov; 119(5):799-802. PubMed ID: 1941389
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Two antiepileptic drugs for intractable epilepsy with complex-partial seizures.
    Schmidt D
    J Neurol Neurosurg Psychiatry; 1982 Dec; 45(12):1119-24. PubMed ID: 6819340
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of epilepsy with clonazepam and its effect on other anticonvulsants.
    Nanda RN; Johnson RH; Keogh HJ; Lambie DG; Melville ID
    J Neurol Neurosurg Psychiatry; 1977 Jun; 40(6):538-43. PubMed ID: 409803
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sodium valproate and clonazepam for treatment-resistant panic disorder.
    Ontiveros A; Fontaine R
    J Psychiatry Neurosci; 1992 Jun; 17(2):78-80. PubMed ID: 1637803
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sodium valproate: pharmacokinetics and effectivensss in treating intractable seizures.
    Redenbaugh JE; Sato S; Penry JK; Dreifuss FE; Kupferberg HJ
    Neurology; 1980 Jan; 30(1):1-6. PubMed ID: 6985719
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasma concentrations of valproate during maintenance therapy in epileptic children.
    Lundberg B; Nergårdh A; Boréus LO
    J Neurol; 1982; 228(2):133-41. PubMed ID: 6185649
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A multiparametric investigation of daytime sleepiness and psychomotor functions in epileptic patients treated with phenobarbital and sodium valproate: a comparative controlled study.
    Manni R; Ratti MT; Perucca E; Galimberti CA; Tartara A
    Electroencephalogr Clin Neurophysiol; 1993 May; 86(5):322-8. PubMed ID: 7685265
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The utility of clonazepam in epilepsy of various types. Observations with 22 childhood cases.
    Nogen AG
    Clin Pediatr (Phila); 1978 Jan; 17(1):71-4. PubMed ID: 618701
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sodium valproate, serum level and clinical effect in epilepsy: a controlled study.
    Gram L; Flachs H; Würtz-Jørgensen A; Parnas J; Andersen B
    Epilepsia; 1979 Jun; 20(3):303-11. PubMed ID: 376307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.